The DAX continues to attract strong inflows, holding firmly within its established range as traders eye a potential breakout above 24,500 euros.
Full FDA approval for one of its drugs, an excellent earnings report, and a deep pipeline support the bullish trend. Is there more room to the upside for Amgen?